Our mission is to make cancer care better for patients, clinicians, and communities. We work at the nexus of research and practice to create, test, and scale solutions to improve health, health care, and health equity for patients with cancer; enhance the patient and clinician experience; and increase care efficiency and value.
Our Initiatives
We are change agents dedicated to designing, testing, scaling and disseminating innovations in cancer care.
Learn more
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
Learn more
We aim to drive high-value cancer care by designing, testing, scaling and evaluating payment models that enhance affordability, access and innovation.
Learn more
We employ a health equity lens across our work, examining and addressing socioeconomic, racial, and ethnic disparities and other systemic barriers to accessing healthcare.
Learn More
We integrate augmented and artificial intelligence into our solutions to predict health outcomes, support decision making, challenge bias, and enhance health equity.
Augmented & Artificial Intelligence
04.22.2024
The Cancer Service Line (CSL) and the Penn Center for Cancer Care Innovation (PC3I) have announced the selection of the 2024 Penn Cancer Innovation Accelerator project. The chosen project, submitted by Katie Boyk, BS, MHA, will identify solutions to improve cancer care scheduling workflows for patients, clinicians, and staff.
02.06.2024
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation announce an academic-community oncology innovation partnership to improve cancer care delivery.
12.05.2023
PC3I Associate Director Surbhi Grover and Deputy Director Katharine Rendle presented research at the 14th AORTIC International Conference on Cancer in Africa, which took place in Dakar, Senegal.
09.27.2023
In an interview with the Philadelphia Inquirer, PC3I Associate Director Lola Fayanju commented on recently updated breast cancer screening recommendations.
02.14.2023
As part of the RadComp study, Penn Medicine and over 20 radiation centers nationwide are comparing the effectiveness of photon therapy and proton therapy to treat breast cancer.
01.12.2023
A team led by PC3I Innovation Faculty Ravi Parikh has found that machine learning-triggered behavioral nudges quadrupled the rates of seriousness illness conversations for patients with advance cancer.